Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
68 USD | +0.04% | +0.41% | +9.27% |
16/05 | Axonics Implant Approved in Australia to Treat Overactive Bladders | MT |
16/05 | Axonics, Inc. Receives Regulatory Approval for Recharge-Free SNM System in Australia | CI |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+9.27% | 3.47B | |
+11.75% | 127B | |
+0.97% | 12.35B | |
-18.47% | 7.1B | |
+56.20% | 6.78B | |
-15.41% | 2.6B | |
-18.25% | 1.91B | |
-27.00% | 1.62B | |
-37.52% | 1.45B | |
-14.29% | 1.1B |
- Stock Market
- Equities
- AXNX Stock
- News Axonics, Inc.
- Transcript : Axonics, Inc. Presents at 41st Annual J.P. Morgan Healthcare Conference, Jan-11-2023 04